Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C1S | P09871 | 2/20 | 1.00 |
| ▸ | PARP1 | P09874 | 1/20 | 0.63 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 6/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 6/20 | 0.57 |
| ▸ | F2 | P00734 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 1/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | F12 | P00748 | 1/20 | 0.52 |
| ▸ | F7 | P08709 | 1/20 | 0.52 |
| ▸ | F3 | P13726 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3764471 | 0.98 | C1S (0.96) | C1SPARP1PRSS1PRSS2PRSS3 | |
| SCHEMBL28569668 | 0.88 | C1S (0.78) | C1SPARP1PRSS1PRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL28572020 | 0.86 | C1S (0.75) | C1SPARP1PRSS1PRSS2PRSS3 | |
| SCHEMBL15547311 | 0.83 | PRSS1 (0.70) | C1SPRSS1PRSS2PRSS3F2 | |
| SCHEMBL27645846 | 0.80 | C1S (0.65) | C1SPARP1PRSS1PRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL28253026 | 0.80 | PRSS1 (0.74) | C1SPRSS1PRSS2PRSS3F2 | |
| Hydrochloric Acid SCHEMBL28555629 | 0.80 | PRSS1 (0.74) | C1SPRSS1PRSS2PRSS3F2 | |
| SCHEMBL24934194 | 0.77 | C1S (0.63) | C1SPARP1SMN1; SMN2KMT2A | |
| SCHEMBL163949 | 0.77 | PARP1 (1.00) | C1SPARP1BLMSMN1; SMN2RECQL | |
| SCHEMBL11346008 | 0.77 | C1S (0.63) | C1SPARP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12384766-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| US-20250171422-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-05-29 | — | — | US | disclosed |
| US-20250057042-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-02-13 | — | — | US | disclosed |
| US-12150380-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-11-19 | — | — | US | disclosed |
| US-20240239752-A1 | BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-07-18 | — | — | US | disclosed |
| US-20240239752-A1 | BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-07-18 | — | — | US | disclosed |
| US-20240239752-A1 | BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-07-18 | — | — | US | disclosed |
| CN-117120419-A | KLK5 bicyclic heteroaromatic inhibitors | 拜奥克里斯特制药公司 | 2023-11-24 | — | — | CN | disclosed |
| US-11708347-B2 | Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708347-B2 | Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20070190355-A1 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | TARGEGEN, INC. (US) | 2007-06-28 | — | — | US | disclosed |
| CN-1918132-A | Method of coloring with capped diazotized compound and coupling component | CIBA SC HOLDING AG (CH) | 2007-02-21 | — | — | CN | disclosed |
| CN-1678285-A | Dyeing method for porous material | CIBA SC HOLDING AG (CH) | 2005-10-05 | — | — | CN | disclosed |
| CN-1615343-A | Yellow cationic dyes for dying of organic material | CIBA SC HOLDING AG (CH) | 2005-05-11 | — | — | CN | disclosed |
| CN-1072967-C | Uncomplexed cyclodextrin solutions for odor control or inanimate surface | PROCTER & GAMBLES CO (US) | 2001-10-17 | — | — | CN | disclosed |
| CN-1308672-A | Laundry detergent and/or fabric care compositions comprising modified transferases | PROCTER & GAMBLE (US) | 2001-08-15 | — | — | CN | disclosed |
| CN-1292814-A | laundry detergent and/or fabric care compositions containing transferase | PROCTER & GAMBLE (US) | 2001-04-25 | — | — | CN | disclosed |
| CN-1269819-A | Food cleaning compositions containing cyclodextrin | PROCTER & GAMBLE (US) | 2000-10-11 | — | — | CN | disclosed |
| CN-1159762-A | Uncomplexed cyclodextrin solutions for odor control or inanimate surface | PROCTER & GAMBLE (US) | 1997-09-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171422-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CRY2 | C1S 66/4885PARP1 800/4885PRSS1 4447/4885 |
| US-20240239752-A1 | BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | KLK5, KLK1, KLKB1 | C1S 1623/4885PARP1 3300/4885PRSS1 48/4885 |
| US-12384766-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | C1S 66/4885PARP1 800/4885PRSS1 4447/4885 |
| US-12150380-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | C1S 66/4885PARP1 800/4885PRSS1 4447/4885 |
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | ABL1, KDR, BCR | C1S 4557/4885PARP1 1420/4885PRSS1 3306/4885 |
| US-20250057042-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CRY2 | C1S 66/4885PARP1 800/4885PRSS1 4447/4885 |
| US-11708347-B2 | Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors | C9, C5, C1QBP | C1S 5/4885PARP1 1015/4885PRSS1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.